Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Intellia Therapeutics, Inc. - Common Stock (NQ:NTLA)

13.73 +0.29 (+2.19%)
Streaming Delayed Price Updated: 1:28 PM EDT, Mar 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Intellia Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
News headline image
Cathie Wood's Ark Invest Sells Tesla Shares Worth $14.5M Amid Rally Driven By Q2 Delivery Numbers, Picks Up Palantir Shares Again Today ↗
 
Via Benzinga
News headline image
3 Stocks Cathie Wood Just Bought to Get Back on Track in the Second Half of 2024 ↗
The popular growth investor is making big moves in July to bounce back after a rough start this year. 
Via The Motley Fool
News headline image
Treasure Hunt: 3 Biotech Stocks Wall Street Hasn’t Discovered Yet ↗
Undiscovered biotech stocks can be risky but rewarding, especially when it involves mid-cap stocks with promise and no profit. 
Via InvestorPlace
News headline image
You’ve Been Warned! 3 Gene Editing Stocks to Buy Now or Regret Forever. ↗
The best gene editing stocks to buy are those with strong tehnogical applications and genuine commercialization prospects. 
Via InvestorPlace
News headline image
Cathie Wood's Ark Invest Acquires $7.3M Worth Of Shares In This Promising Netflix Competitor, Sells Off Coinbase Stock Amid Bitcoin Slump ↗
On Wednesday, Cathie Wood-led Ark Invest made significant trades in Roku Inc (NASDAQ:ROKU) and Coinbase Global Inc (NASDAQ:COIN), amidst a volatile market. 
Via Benzinga
News headline image
Unveiling 6 Analyst Insights On Intellia Therapeutics ↗
 
Via Benzinga
News headline image
Cracking The Code: Understanding Analyst Reviews For Intellia Therapeutics ↗
 
Via Benzinga
News headline image
3 Gene Editing Stocks That Could Make Your Grandchildren Rich ↗
Explore gene-editing stocks with long-term growth potential, offering innovative solutions to previously untreatable conditions. 
Via InvestorPlace
News headline image
RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More ↗
Biotech investing is risk-fraught but the returns could be staggering if one chooses to take the educated approach. 
Via Benzinga
News headline image
Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for June 2024 ↗
Investors looking for companies with high growth potential should consider investing in these three strong buy Cathie Wood stocks. 
Via InvestorPlace
News headline image
Avidity Biosciences And CleanSpark Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 9-June 15): Are These In Your Portfolio? ↗
Top mid-cap performers: Avidity Biosciences, Iris Energy, Hims & Hers Health, John Wiley & Sons, Element Solutions, CleanSpark, Enovix Corp, Axcelis Tech, Intellia Therapeutics, Korn Ferry. 
Via Benzinga
News headline image
Why Intellia Therapeutics, Inc. Outpaced the Stock Market ↗
Investors will be eagerly watching for the performance of Intellia Therapeutics, Inc. in its upcoming earnings disclosure. 
Via Talk Markets
News headline image
Cathie Wood-Lead Ark Invest Dumps $7.6M Worth Of Robinhood Shares Amid GameStop Buzz, Bitcoin Choppiness ↗
On Monday, Cathie Wood-led Ark Invest made a significant move by reducing its holdings in Robinhood Markets Inc (NASDAQ:HOOD). This decision came amidst a period of market fluctuations and followed a... 
Via Benzinga
News headline image
Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought ↗
These companies could generate explosive growth over time. 
Via The Motley Fool
News headline image
These 2 Words Are Why Intellia Therapeutics Could Be a Smart Buy Right Now ↗
Neither word has anything to do with money -- at least not yet. 
Via The Motley Fool
News headline image
Cathie Wood-Led Ark Invest Buys $9.9M Worth Of Amazon Shares, Also Picks Up Reddit Stock ↗
 
Via Benzinga
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
The widely followed growth investor made big moves as May came to a close. 
Via The Motley Fool
News headline image
The 3 Best Biotech Stocks to Buy in June 2024 ↗
Explore the best biotech stocks to buy in June 2024, with insights on Protagonist, BridgeBio and Intellia. 
Via InvestorPlace
News headline image
Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You? ↗
In keeping with Cathie Wood's style, these picks are riskier than average. 
Via The Motley Fool
News headline image
Why Intellia Therapeutics Shares Are Trading Higher Monday ↗
Intellia's NTLA-2002 is an experimental CRISPR based gene-editing therapy being developed as a one-time treatment for hereditary angioedema (HAE). The company announced the single does treatment led to... 
Via Benzinga
News headline image
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
Cathie Wood-Led Ark Invest Sells Nearly $28M Worth Of Robinhood Shares Amid Crypto API Launch And Lackluster Bitcoin Price Action ↗
On Thursday, Cathie Wood-led Ark Invest made notable adjustments to its portfolio, including a significant sell-off of Robinhood Markets Inc (NASDAQ:HOOD) shares. 
Via Benzinga
News headline image
Cathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF ↗
Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showcasing the challenges faced by some of its major holdings. 
Via Benzinga
Topics ETFs
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
The popular growth investor keeps adding to some of her favorite falling stocks. 
Via The Motley Fool
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
The popular growth investor bought into one of Thursday's biggest losers and two stocks that have fallen sharply over the past year. 
Via The Motley Fool
News headline image
NTLA Stock Earnings: Intellia Therapeutics Beats EPS, Beats Revenue for Q1 2024 ↗
NTLA stock results show that Intellia Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Just Say No to Drugs: 3 Pharma Stocks to Avoid ↗
Discover which pharma stocks to avoid in 2023 as we delve into market trends, financial struggles, and the impact on investor portfolios. 
Via InvestorPlace
News headline image
Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street’s Radar ↗
The gene editing stocks are worth tuning into as some investors out there discount their innovative, albeit early-stage pipelines. 
Via InvestorPlace
News headline image
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire ↗
Pay close attention to gene editing stocks. By 2028, according to MarketsandMarkets, the market could be worth about $10.6 billion. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.